Kromek emerges from the 2021 financial year in a stronger position

Kromek Group plc (LON:KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, has announced its final results for the year ended 30 April 2021.

Financial Summary

·      Revenue of £10.4m (2020: £13.1m)

·      Gross margin was 48.4% (2020: 47.3%)

·      Adjusted EBITDA* loss of £1.7m (2020: £0.4m loss)

·      Loss before tax was £6.3m (2020: £18.3m loss)

·      Cash and cash equivalents at 30 April 2021 were £15.6m (30 April 2020: £9.4m)

*Adjusted EBITDA is defined as earnings before interest, taxation, depreciation, amortisation, exceptional items, early settlement discounts and share-based payments. For further details, see the Financial Review below.

Operational Summary

·         Resumption of orders and shipments across all segments in final two months of the first half, following the impact of COVID-19, with increased commercial activity in the second half, resulting in revenue for H2 2021 being 26% higher than H1 2021

·         Medical imaging segment returned to growth trajectory in the second half of the year  

o   Ramp up in delivery under medical imaging contract expected to be worth $58.1m as the customer began installing its scanner in multiple countries

o   Received a $600,000 order from an OEM customer for detectors to be used in niche SPECT applications

o   Progressed development programme for ultra-low dose MBI technology and entered the new area of improving outcomes from cancer surgery  

·         Continuing commercial traction and development of nuclear security products, with sales in Europe, the US and Asia

o   Expansion of global footprint with sales commencing in 9 new countries and engagement of 9 new distributors  

o   Continued to supply products to government agencies in the US and UK; the Irish Civil Defence; and the European Commission 

o   Completion of development project with the Defense Threat Reduction Agency (“DTRA”), an agency of the US Department of Defense, for a ruggedised small form factor nuclear radiation detector for military applications 

o   Launch of next-generation D3 PRD and D5 RIID high-performance radiation detectors  

·         24 new customers won in the civil nuclear segment and widening interest for drone-based radiation mapping system, including sales to the civil emergency services sector 

·         Significant progress in fast-growing bio-security market  

o   Awarded $5.2m contract extension in the year and a further $6m post period by the Defense Advanced Research Projects Agency (“DARPA”), an agency of the US Department of Defense, to advance the development of a mobile wide-area bio-security system capable of detecting and identifying airborne pathogens  

·         Commenced field trials in an airport and, post period, in schools, airports and other locations of an airborne COVID-19 detection system under a £1.25m project with funding from Innovate UK

·         Received first commercial order from security screening OEM customer that achieved highest level of European liquid explosive detection certification for cabin baggage for its scanner 

·         Continued improvement in CZT manufacturing processes in the UK and US facilities, including introduction of further process automation

·         3 new patents were filed and 10 were granted during the year 

Dr Arnab Basu, CEO of Kromek, said: Against a backdrop of significant global uncertainty, Kromek has emerged from the 2021 financial year in a stronger position than when we entered. While the disruption across our markets in the early part of the year impacted our sales, our revenue for the second half was 26% above the first half, with the strong momentum continuing post year end. In particular, we are seeing continued traction in the medical imaging segment as our customers increasingly roll out their products incorporating our technology. We are extremely encouraged by the results that we are receiving from the piloting of our biological-threat detection solution. We also believe that we are well-positioned to benefit from the increase in government defence and security spending globally, including in the UK, as evidenced by our announcement today of the receipt of our first major order for our D5 RIID.

As a result, and with excellent visibility over full year forecasts, we are on track to deliver our highest ever annual revenue for the full year to 30 April 2022, representing significant growth over 2021. Consequently, and combined with the successful fundraising completed in the year under review, we are well-placed to capitalise on the substantial opportunities across our business and the Board continues to look to the future with increased confidence.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Kromek

More articles like this

Kromek

Kromek secures £5m contract with a UK Government department

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured a contract with a UK Government department to develop and supply biological threat detection

Kromek

Kromek presents at the NATO TIDE Sprint #40 event

Kromek, the County Durham-based developer and manufacturer of biological and radiological detection equipment, presented a paper at the Fall 2022 NATO TIDE Sprint #40 symposium being held from 24-28 October 2022 in Virginia Beach, USA. TIDE is the NATO Think-Tank for

Kromek

The AARM – Survey large areas safely

Got a project in mind? So you need to complete a widespread environmental survey, get the go ahead for a mining or infrastructure development project. Maybe you need to plan your next steps in decommissioning a powerplant, or

Kromek

Kromek returns to the Counter Threat Symposium 2022

Kromek, the County Durham-based developer and manufacturer of biological and radiological detection equipment, will be exhibiting at the Counter Threat Symposium 2022 at the Farnborough International Exhibition and Conference Centre, stand 5, from 8-10 November 2022. The Counter

Kromek

Spectrum Dynamics integrates CZT detectors in VERITON-CT 400 series

Spectrum Dynamics Medical has integrated cadmium zinc telluride (CZT) detectors from Kromek Group in its digital SPECT/CT products called the VERITON-CT 400 series. CZT is a room-temperature semiconductor, which directly transforms x-ray or gamma photons into electrons and holes. It is said to

Kromek

Kromek’s busy September

Kromek, the Country Durham-based developer and manufacturer of radiation detection equipment had a very busy September as the company exhibited its latest systems and products at three national and international exhibitions. For the second year in a row,

Kromek

Kromek to attend the International Security Expo

Kromek, the Country Durham-based developer and manufacturer of radiation detection equipment will exhibit its latest systems and products at the 2022 International Security Expo being held in London. Stand A58 Counter Threat Pavilion. At the Expo this year, where a

Kromek

New threats and problems need modern solutions

The threats the World faces from Chemical Biological Radiological and Nuclear (CBRN) substances are probably higher than they have ever been. Arguably, biological, radiological and nuclear weapons of mass destruction now present the biggest challenges, necessitating a global

Kromek

Kromek AARM System Demonstration – Drones and Dogs

Kromek Group plc designs, develops and produces x-ray and gamma-ray imaging and radiation detection products for the medical, CBRNe security, Homeland Security and civil nuclear radiation detection markets. 

Kromek

Kromek at The Emergency Services Show 2022

Kromek will be exhibiting at the The Emergency Services Show from Wednesday 21st to Thursday 22nd September 2022 at Hall 5, The National Exhibition Centre (NEC), Birmingham. We will be showcasing our world leading radiation detection solutions, including our D3S ID, a discreet, wearable, lightweight RIID

Kromek

Kromek at CBRNe Protection Symposium 2022

Kromek will be exhibiting at the CBRNe Protection Symposium 2022 from Tuesday 20th to Thursday 22nd September 2022 at Malmö, Sweden. We will be showcasing our world leading radiation detection solutions, including our D3S ID, a discreet, wearable, lightweight RIID designed for first responders,

No more posts to show